Inspire Announces Presentations at Two European Scientific Conferences
...nastine HCI ophthalmic solution)0.05% for allergic conjunctivitis and Restasis(R) (cyclosporineophthalmic emulsion) 0.05% for dry eye. Inspire is focused on thetherapeutic areas of ophthalmology and respiratory/allergy, and isdeveloping products for dry eye, cystic fibrosis, allergic rhinitisand glaucoma. Elestat a......, the potential ofbepotastine of treating allergic conjunctivitis and of providingallergy sufferers with comprehensive protection for the treatmentof their ophthalmic and nasal symptoms, the potential ofbepotastine, if approved by the FDA, to quickly become a favoriteamongst physicians and their patients suffering ......nastine HCl ophthalmic solution)0.05% for allergic conjunctivitis and Restasis(R) (cyclosporineophthalmic emulsion) 0.05% for dry eye. Inspire is focused on thetherapeutic areas of ophthalmology and respiratory/allergy, and isdeveloping products for dry eye, cystic fibrosis, allergic rhinitisand glaucoma. Elestat a......nastine HCI ophthalmic solution)0.05% for allergic conjunctivitis and Restasis(R) (cyclosporineophthalmic emulsion) 0.05% for dry eye. Inspire is focused on thetherapeutic areas of ophthalmology and respiratory/allergy, and isdeveloping products for dry eye, cystic fibrosis, allergic rhinitisand glaucoma. Elestat a...